Monoclonal antibodies as prognostic indicators of tumor progression in breast cancer
- PMID: 2464907
- DOI: 10.1007/978-1-4899-5037-6_35
Monoclonal antibodies as prognostic indicators of tumor progression in breast cancer
Similar articles
-
Epitopes with diagnostic and prognostic significance co-expressed on a human breast carcinoma-associated antigen.Eur J Cancer Clin Oncol. 1986 Jan;22(1):115-7. doi: 10.1016/0277-5379(86)90351-2. Eur J Cancer Clin Oncol. 1986. PMID: 2420604 No abstract available.
-
[Different expressions of various epitopes of the Thomsen-Friedenreich antigen in breast cancer cells. Immunohistochemical study with monoclonal antibodies against asialoglycophorin A].Verh Dtsch Ges Pathol. 1985;69:218-21. Verh Dtsch Ges Pathol. 1985. PMID: 2420088 German. No abstract available.
-
Breast-cancer-associated antigens defined by monoclonal antibodies.Subcell Biochem. 1988;12:1-30. doi: 10.1007/978-1-4899-1681-5_1. Subcell Biochem. 1988. PMID: 2457264 Review. No abstract available.
-
[Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].Pathologe. 1991 Mar;12(2):60-5. Pathologe. 1991. PMID: 1711692 German. No abstract available.
-
[Monoclonal antibodies in mammary carcinoma].Medicina (B Aires). 1988;48(3):311-20. Medicina (B Aires). 1988. PMID: 3073296 Review. Spanish. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical